Krenczkowska, D.; Mojsiewicz-Pieńkowska, K.; Wielgomas, B.; Bazar, D.; Jankowski, Z.
Ex Vivo Human Skin is not a Barrier for Cyclic Siloxanes (Cyclic Silicones): Evidence of Diffusion, Bioaccumulation, and Risk of Dermal Absorption Using a New Validated GC-FID Procedure. Pharmaceutics 2020, 12, 586.
https://doi.org/10.3390/pharmaceutics12060586
AMA Style
Krenczkowska D, Mojsiewicz-Pieńkowska K, Wielgomas B, Bazar D, Jankowski Z.
Ex Vivo Human Skin is not a Barrier for Cyclic Siloxanes (Cyclic Silicones): Evidence of Diffusion, Bioaccumulation, and Risk of Dermal Absorption Using a New Validated GC-FID Procedure. Pharmaceutics. 2020; 12(6):586.
https://doi.org/10.3390/pharmaceutics12060586
Chicago/Turabian Style
Krenczkowska, Dominika, Krystyna Mojsiewicz-Pieńkowska, Bartosz Wielgomas, Dagmara Bazar, and Zbigniew Jankowski.
2020. "Ex Vivo Human Skin is not a Barrier for Cyclic Siloxanes (Cyclic Silicones): Evidence of Diffusion, Bioaccumulation, and Risk of Dermal Absorption Using a New Validated GC-FID Procedure" Pharmaceutics 12, no. 6: 586.
https://doi.org/10.3390/pharmaceutics12060586
APA Style
Krenczkowska, D., Mojsiewicz-Pieńkowska, K., Wielgomas, B., Bazar, D., & Jankowski, Z.
(2020). Ex Vivo Human Skin is not a Barrier for Cyclic Siloxanes (Cyclic Silicones): Evidence of Diffusion, Bioaccumulation, and Risk of Dermal Absorption Using a New Validated GC-FID Procedure. Pharmaceutics, 12(6), 586.
https://doi.org/10.3390/pharmaceutics12060586
